Corteva (NYSE: CTVA) insider transactions
In the twelve months to 10 November 2026, executives and directors of Corteva reported 2 open-market sales of 8,311 shares ($636,213) and 0 open-market purchases, by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 30 October 2026 | Giesselman Janet Plaut | Director | Grant or award | +666 | $11.64 | 20,956 | Form 4 |
| 30 October 2026 | Nayyar Nayaki R | Director | Grant or award | +2,792 | $11.64 | 39,625 | Form 4 |
| 30 October 2026 | Policinski Christopher J. | Director | Grant or award | +2,792 | $11.64 | 5,566 | Form 4 |
| 1 October 2026 | Kissam Luther C Iv | Chief Executive Officer | Other | −127,949 | — | 153,087 | Form 4 |
| 1 October 2026 | Titus Brian | See Remarks | Other | −13,315 | — | 23,379 | Form 4 |
| 1 October 2026 | Titus Brian | See Remarks | Other | −11,083 | — | 34,462 | Form 4 |
| 16 September 2026 | Johnson David Paul | EVP, Chief Financial Officer | Shares withheld for tax | −8,517 | $81.01 | 73,626 | Form 4 |
| 15 September 2026 | Johnson Jennifer Amy | SVP, Chief Legal Officer | Shares withheld for tax | −446 | $83.39 | 16,849 | Form 4 |
| 31 July 2026 | Policinski Christopher J. | Director | Grant or award | +413 | $78.71 | 2,769 | Form 4 |
| 31 July 2026 | Giesselman Janet Plaut | Director | Grant or award | +98 | $78.71 | 20,248 | Form 4 |
| 31 July 2026 | Nayyar Nayaki R | Director | Grant or award | +413 | $78.71 | 36,754 | Form 4 |
| 1 June 2026 | Kissam Luther C Iv | CEO, Crop Protection Business | Grant or award | +24,138 | — | 25,138 | Form 4 |
| 30 April 2026 | Lutz Marcos M | Director | Shares withheld for tax | −906 | $81.01 | 63,053 | Form 4 |
| 30 April 2026 | Giesselman Janet Plaut | Director | Grant or award | +96 | $81.01 | 20,103 | Form 4 |
| 30 April 2026 | Nayyar Nayaki R | Director | Grant or award | +401 | $81.01 | 36,255 | Form 4 |
| 30 April 2026 | Engel Klaus A | Director | Shares withheld for tax | −906 | $81.01 | 40,219 | Form 4 |
| 28 April 2026 | Everitt David C | Director | Grant or award | +2,350 | — | 19,738 | Form 4 |
| 28 April 2026 | Page Gregory R | Director | Grant or award | +3,870 | — | 69,074 | Form 4 |
| 28 April 2026 | Ward Pat | Director | Grant or award | +2,350 | — | 38,432 | Form 4 |
| 28 April 2026 | Preete Kerry J | Director | Grant or award | +2,350 | — | 18,467 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Corteva page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.